Re-188-Etidronate (HEDP)
188Re-Etidronate (188Re-HEDP) is a therapeutic agent for bone metastases treatment. [...]
Lu-177-IPN-01087
177Lu-IPN-01087 (177Lu-3BP-227) is a neurotensin antagonist peptide labeled with 177Lu [...]
Lu-177-Edotreotide (Solucin®)
177Lu-Edotreotide (177Lu--Octreotide, 177Lu-Solucin®) is a radiolabeled somatostatin analogue developed [...]
Lu-177-TLX250
177Lu-TLX250 (177Lu-Lutarex®, 177Lu-Girentuximab), a Lutetium-177-labeled monoclonal antibody is being developed [...]
Lu-177-Lilotomab Satetraxetan (Betalutin)
Betalutin™ is the brand name of an anti-CD37 antibody labeled [...]
Re-188-Rhenium Lipiodol
188Re-HDD/Lipiodol is a generic therapeutic in form of a mixture [...]
Re-188-P2045 (Tozaride)
188Re-P2045 (BAY86-5284, Tozaride) is a 11-amino acid proprietary somatostatin [...]
Y-90-DOTALAN (Lanreotide)
90Y-DOTALAN (90Y-Lanreotide, 90Y-Somatulin) is a generic drug that specifically binds [...]
Y-90-DOTATOC (Edotreotide)
90Y-Edotreotide (90Y-DOTATOC, 90Y-Onalta®) is a drug which is actually developed [...]
Y-90-OPS201 (SOMTher®)
90Y-OPS201 (90Y-DOTA-JR11, 90Y-SOMTher®) is a proprietary drug that specifically binds [...]